SUCLG2 and neoplasm: While this pathway is functional in normal cells, it is suppressed in lung adenocarcinoma cells due to reduced TRIM21 activity or expression, leading to SUCLG2 succinylation, increased stability, abnormal accumulation, and enhanced tumor cell proliferation.